Sudarshan Pharma Ind

SUDARSHAN
Price
-- --
 
Micro Cap
₹961 Cr.
Sudarshan Pharma Industries Limited is engaged in contract manufacturing, outsource & Supply of Generic Pharma formulation and medicines to healthcare institution, Government, NGO and Hospitals. … More
Sudarshan Pharma Industries Limited is engaged in contract manufacturing, outsource & Supply of Generic Pharma formulation and medicines to healthcare institution, Government, NGO and Hospitals. It outsource its manufacturing facility, deal in Import and Exports, indenting and Supply in Specialty chemicals, API & its intermediate. As per the clients need and requirement, it provide order and get them manufactured from various suppliers in India and abroad regularly. Less
Sudarshan Pharma Industries Limited is engaged in contract manufacturing, outsource & Supply of… More
Sudarshan Pharma Industries Limited is engaged in contract manufacturing, outsource & Supply of Generic Pharma formulation and medicines to healthcare institution, Government, NGO and Hospitals. It outsource its manufacturing facility, deal in Import and Exports, indenting and Supply in Specialty chemicals, API & its intermediate. As per the clients need and requirement, it provide order and get them manufactured from various suppliers in India and abroad regularly. Less
Low
18.50
52W Range
High
38.99
PE
41.24
Sector PE
30.43
P/B
6.2
Div.Yield
--
ROE
12.14%
EBIDTA
24.23
ROCE
28.18
EPS
0.45
WhatsApp

Get instant stock alerts
  • Share Price
  • Financials
  • Revenue mix
  • Shareholdings
  • Peers
  • Forensics
Niche index constructed using market cap and revenue exposure of companies in this sector

Coming soon

  • 5D
  • 1M
  • 6M
  • YTD
  • 1Y
  • 5Y
  • MAX

  • Summary

  • Profit & Loss

  • Balance sheet

  • Cashflow

Yearly | Quarterly
View Detailed Summary View Detailed Summary

This data is currently unavailable for this company.

Yearly | Quarterly
(In Cr.)
(In Cr.)

This data is currently unavailable for this company.
Financial Ratio's
(In %)
Detailed P&L Report Detailed P&L Report
(In Cr.)
Detailed Balance Sheet
Financial Year (In Cr.)
Detailed Cash Flow

  • Product wise

  • Location wise

SUDARSHAN
Revenue Mix
    Latest
    |
    Historic

    This data is currently unavailable for this company.

    SUDARSHAN
    Revenue Mix
    Latest
    |
    Historic

    This data is currently unavailable for this company.

    More Info

    Shareholdings

    Holders
    Detailed Shareholdings

    This data is currently unavailable for this company.

    Peers
    Detailed Peers

    Forensics

    View Detailed Forensics

    Recent events

    • News

    • Corporate Actions

    Sudarshan Pharma Industries To Consider Fund Raising Via Equity, Convertibles, Warrants Or Debt
    Jun 15, 2026
    Warrant Conversion
    Jun 12, 2026
    Sudarshan Pharma Industries Incorporates Sudarshan Industries Inc As Subsidiary In USA
    Jun 10, 2026
    Sudarshan Pharma Industries Ltd To Consider Issuance Of Foreign Currency Convertible Bonds
    May 12, 2026
    Sudarshan Pharma Industries Says GST Inspection Conducted By Mumbai Tax Department
    Feb 26, 2026
    Sudarshan Pharma Industries Appoints Sachin Mehta As CFO
    Aug 14, 2025
    Sudarshan Pharma Industries CFO Manoj Lodha Resigns
    Aug 05, 2025
    Sudarshan Pharma Industries To Incorporate Wholly Owned Subsidiary In USA
    Jun 19, 2025
    Sudarshan Pharma Industries Gets One Star Export House Certificate From Government
    Jun 04, 2025
    Sudarshan Pharma Industries To Acquire 300 Shares Of Cibachem
    May 13, 2025
    Sudarshan Pharma Industries Says Sachin Mehta Resigns As CFO Effective April 1, 2025
    Mar 06, 2025
    Sudarshan Pharma Industries Approves Incorporation Of Unit In Poland
    Feb 19, 2025
    Sudarshan Pharma Industries To Raise 1.88 Billion Rupees Via Preferential Issue
    Jan 10, 2025
    Sudarshan Pharma Industries To Buy Shares In Sudarshan Pharma Industries For S$10,000
    Nov 29, 2024
    Sudarshan Pharma Industries To Acquire 51% Stake Of Ishwari Healthcare
    Oct 14, 2024
    Sudarshan Pharma Industries Approves Sub-Division Of 1 Share Into 10 Shares
    Sep 30, 2024
    Sudarshan Pharma Industries To Consider Proposal For Sub-Division Of Shares
    Sep 24, 2024
    Sudarshan Pharma Industries To Consider Raising Of Funds
    Jul 01, 2024
    Sudarshan Pharma Industries Taking Legal Recourse Against Regan International DMCC
    Jan 02, 2024
    Sudarshan Pharma Industries Names Sachin Mehta As CFO
    Dec 12, 2023
    Sudarshan Pharma Industries CFO Dharam Jilka Resigns
    Sep 15, 2023
    Sudarshan Pharma Industries Says Unit Incorporated In The Name Of Lifescience Chemicals
    Aug 24, 2023
    Sudarshan Pharma Industries To Incorporate A Subsidiary Company Named Lifescience Chemicals
    Aug 18, 2023
    Sudarshan Pharma Industries Approves Acquisition Of 100% Stake In Ratna Lifesciences Pvt Ltd
    Aug 09, 2023
    Sudarshan Pharma Industries To Consider Acquisition Of Ratna Lifesciences As Unit
    Jul 27, 2023
    Sudarshan Pharma Industries Re‐Appoints Hemal Mehta As Managing Director
    Jul 21, 2023
    Events:
    Announcement Date
    Apr 30, 2026
    Announcement Date
    Jan 28, 2026
    Announcement Date
    Oct 18, 2025
    Announcement Date
    Aug 14, 2025
    Announcement Date
    Jul 01, 2025
    Announcement Date
    Apr 24, 2025
    Split
    1 shares held will now become 10. New number of shares should be credited and listed within 1 day after the ex-date.
    Ex Date
    Nov 22, 2024
    Announcement Date
    Oct 31, 2024
    Announcement Date
    Sep 05, 2024
    Announcement Date
    May 27, 2024
    Announcement Date
    Nov 10, 2023
    Dividend
    Dividend of Rs.0.3 per share
    Ex Date
    Aug 25, 2023
    Announcement Date
    Aug 10, 2023
    Announcement Date
    May 26, 2023

    More Micro Cap Ideas

    See similar 'Micro' cap companies with recent activity

    Promoter Buying

    Companies where the promoters are bullish

    Detailed List

    Capex

    Companies investing on expansion

    Detailed List

    Superstar Investor

    Companies where well known investors have invested

    Detailed List